BetaCellsInDiabetes.org is a resource for physicians and healthcare professionals.
The information found here is not a substitute for medical advice, diagnosis or treatment.
The risk of developing a range of solid tumours is increased in type 2 diabetes, and may be influenced by glucose-lowering therapies. We examined the risk of development of solid tumours in relation to treatment with oral agents, human insulin and insulin analogues.
BetaCellsInDiabetes.org is a resource for physicians and healthcare professionals.
The information found here is not a substitute for medical advice, diagnosis or treatment.